How Lyme Disease Is Diagnosed: A Practical Guide for Patients and Clinicians
Clinical diagnosis comes first
Testing supports but does not replace judgment
Early recognition may improve outcomes
As we continue to grapple with the long-term effects of COVID-19 and deepen our understanding of post-infectious syndromes like Long COVID, it has become increasingly clear: not all infections resolve cleanly. Some linger, disrupt multiple systems, and defy simplistic explanations.
Lyme disease is one of those conditions.
For years, Lyme disease has presented diagnostic challenges. Symptoms may be vague, migratory, or involve multiple body systems. Testing may be unreliable—especially early in the disease. As a result, some patients are told they do not have Lyme disease even as symptoms continue to evolve.
As a physician experienced in treating the chronic manifestations of Lyme disease, I have developed a practical three-step framework to help clinicians recognize Lyme disease more accurately—and earlier. This approach prioritizes clinical judgment, symptom evolution, and collaboration when needed.
Step 1: Recognize the Clinical Syndrome
The first step in diagnosing Lyme disease is determining whether the patient’s symptoms fit a recognizable clinical pattern.
Early signs may include:
- Erythema migrans (EM) rash
- Fever, chills, fatigue
- Headache and muscle aches
Later or persistent signs may include:
- Migratory joint pain, especially involving the knees
- Facial palsy
- Neuropathic pain
- Cognitive dysfunction (“brain fog”)
- POTS (Postural Orthostatic Tachycardia Syndrome)
- Mood changes and sleep disturbance
Many of these findings are discussed in greater detail in our guide to Lyme disease symptoms.
Lyme disease remains a clinical diagnosis, particularly in its early stages. If an erythema migrans rash is present, treatment should begin immediately and testing is not required. If the rash is absent but the exposure history and symptom pattern suggest Lyme disease, laboratory testing may support the diagnosis but should not replace clinical judgment.
A thorough exposure history is essential. Ask about tick exposure, geography, outdoor activity, seasonality, and any prior flu-like illness that may have gone unrecognized.
Step 2: Evaluate Stage and Complexity
Next, assess how far the illness has progressed and how many systems are involved.
Stages of Lyme disease may include:
- Localized: EM rash and flu-like symptoms
- Disseminated: Joint pain, Bell’s palsy, POTS, and cardiac symptoms
- Persistent or chronic manifestations: Fatigue, cognitive dysfunction, neuropathy, and autonomic instability
Ask about prior antibiotic treatment and whether symptoms returned, evolved, or worsened over time. Many patients who later develop persistent symptoms were diagnosed late or treated after the disease had already disseminated.
It is also important to consider tick-borne co-infections such as Babesia, Bartonella, Ehrlichia, and Anaplasma. These infections can complicate recovery and may contribute to neurologic, autonomic, or systemic symptoms.
Step 3: Use Labs Judiciously and Interpret Them in Context
The standard CDC two-tier testing approach (ELISA followed by Western blot) remains widely used but has important limitations.
- Lower sensitivity early in infection
- May be negative despite compatible symptoms
- Originally developed for surveillance rather than ruling out individual cases
Understanding the strengths and limitations of Lyme disease testing is critical when evaluating complex patients.
If clinical suspicion is high and testing is negative, laboratory results alone should not dictate decision-making. Lyme disease diagnosis requires integrating symptoms, exposure history, examination findings, and testing.
Additional evaluations may include:
- Co-infection testing when clinically appropriate
- CBC, CMP, CRP, and liver enzymes for supportive findings
- Thyroid, vitamin D, and B12 testing when fatigue and neurologic symptoms persist
When complexity increases—particularly with neurologic, cardiac, or psychiatric symptoms—consultation with a clinician experienced in Lyme disease may help clarify diagnosis and treatment options.
Referral is not a sign of uncertainty. It is often part of providing thorough patient-centered care.
Why Accurate Diagnosis Matters
Like Long COVID, Lyme disease highlights the limitations of protocol-driven care when illness does not follow a predictable pattern. Diagnosis is often built not only on laboratory testing, but also on pattern recognition, careful listening, and clinical judgment.
Some patients present with textbook findings. Others do not. The challenge is recognizing the broader clinical picture when symptoms span multiple systems and evolve over time.
Frequently Asked Questions
Can Lyme disease be diagnosed without a positive test?
Yes. Lyme disease is primarily a clinical diagnosis. An erythema migrans rash alone is sufficient for diagnosis and treatment.
How accurate are Lyme disease tests?
Testing may be less sensitive early in infection and should always be interpreted alongside symptoms, exposure history, and clinical findings.
When should a patient be referred to a Lyme disease specialist?
Referral may be helpful when symptoms are complex, persistent, involve multiple systems, or remain unexplained despite evaluation.
Can co-infections affect Lyme disease diagnosis?
Yes. Babesia, Bartonella, Anaplasma, and Ehrlichia can complicate symptoms and may influence both diagnosis and treatment decisions.
Clinical Takeaway
Diagnosing Lyme disease requires more than laboratory testing alone. Careful attention to symptoms, exposure history, disease stage, and co-infections can improve diagnostic accuracy and help identify patients who may benefit from earlier treatment or specialist consultation.
Early recognition, thoughtful clinical judgment, and collaboration when needed remain the foundation of effective Lyme disease diagnosis.
Related Articles
How accurate are Lyme disease tests?
Lyme disease symptoms guide
Tick-borne co-infections
Delayed Lyme disease diagnosis
Recovery from Lyme disease
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
